002644.SZ · 佛慈制药
China A-shares · RS rating 80 · As of 2026-10-14
| Price | 8.15 CNY |
|---|---|
| 1-day change | -1.2% |
| RS rating (overall / 1M / 3M / 12M) | 80 / 54 / 82 / 62 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 36 / 44 / 33 |
| Industry group (rank) | Medical-Generic Drugs (40) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | +8.1% |
| Distance from 52-week high | +18.7% |
| Market cap (USD) | $640.7M |